Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,679 | Dovepress* | 7,842+ | 1,563 | 9,405 | |
PubMed Central* | 3,837 | 838 | 4,675 | ||
Totals | 11,679 | 2,401 | 14,080 | ||
*Since 8 February 2019 |
View citations on PubMed Central and Google Scholar